These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 8878382)
41. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema. Saad R; Gritsch HA; Shapiro R; Jordan M; Vivas C; Scantlebury V; Demetris AJ; Randhawa PS Transplantation; 1997 Oct; 64(7):992-5. PubMed ID: 9381547 [TBL] [Abstract][Full Text] [Related]
42. Sub-clinical acute rejection detected using protocol biopsies in patients with delayed graft function. Jain S; Curwood V; White SA; Furness PN; Nicholson ML Transpl Int; 2000; 13 Suppl 1():S52-5. PubMed ID: 11111961 [TBL] [Abstract][Full Text] [Related]
43. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Boratyńska M; Banasik M; Patrzałek D; Klinger M Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290 [TBL] [Abstract][Full Text] [Related]
44. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351 [TBL] [Abstract][Full Text] [Related]
45. A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management. Dean DE; Kamath S; Peddi VR; Schroeder TJ; First MR; Cavallo T Transplantation; 1999 Sep; 68(5):642-5. PubMed ID: 10507482 [TBL] [Abstract][Full Text] [Related]
46. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613 [TBL] [Abstract][Full Text] [Related]
47. Long-term beneficial effect of tacrolimus conversion on renal transplant recipients. Lee WC; Lian JD; Wu MJ; Cheng CH; Chen CH; Shu KH Ren Fail; 2005; 27(5):501-6. PubMed ID: 16152986 [TBL] [Abstract][Full Text] [Related]
48. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988 [TBL] [Abstract][Full Text] [Related]
49. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827 [TBL] [Abstract][Full Text] [Related]
50. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092 [TBL] [Abstract][Full Text] [Related]
51. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. Heilman RL; Cortese C; Geiger XJ; Younan K; Wadei HM; Mai ML; Reddy KS; Gonwa TA Transplantation; 2012 Jan; 93(1):47-53. PubMed ID: 22067270 [TBL] [Abstract][Full Text] [Related]
52. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838 [TBL] [Abstract][Full Text] [Related]
53. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878 [TBL] [Abstract][Full Text] [Related]
54. New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection. Chen LM; Godinez J; Thisted RA; Woodle ES; Thistlewaite JR; Powers C; Haraf D Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):999-1003. PubMed ID: 10705023 [TBL] [Abstract][Full Text] [Related]
55. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
56. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Chenhsu RY; Loong CC; Chou MH; Lin MF; Yang WC Ann Pharmacother; 2000 Jan; 34(1):27-31. PubMed ID: 10669182 [TBL] [Abstract][Full Text] [Related]
57. Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy. Pilmore HL; Dittmer ID Clin Transplant; 2002 Jun; 16(3):191-5. PubMed ID: 12010142 [TBL] [Abstract][Full Text] [Related]
59. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948 [TBL] [Abstract][Full Text] [Related]
60. Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules. Moreso F; Alperovich G; Fulladosa X; Gil-Vernet S; Ibernon M; Carrera M; Castelao AM; Hueso M; Grinyo JM; Serón D Transplant Proc; 2003 Aug; 35(5):1666-8. PubMed ID: 12962749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]